Akzo Nobel N.V.
AKZA.AS
56.34
EUR+0.14
(+0.25%)Day's range
55.78
56.68
52 wk Range
48.64
66.18
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 8,530,000,000 | 9,587,000,000 | 10,846,000,000 | 10,668,000,000 | 10,711,000,000 | |
| Gross Profit | 3,785,000,000 | 3,855,000,000 | 3,923,000,000 | 4,234,000,000 | 4,337,000,000 | |
| Operating Income | 963,000,000 | 1,118,000,000 | 708,000,000 | 1,029,000,000 | 917,000,000 | |
| Net Income | 630,000,000 | 829,000,000 | 352,000,000 | 442,000,000 | 542,000,000 | |
| Total Assets | 13,177,000,000 | 13,878,000,000 | 14,741,000,000 | 14,904,000,000 | 14,249,000,000 | |
| Total Current Liabilities | 3,093,000,000 | 4,869,000,000 | 5,746,000,000 | 5,706,000,000 | 4,730,000,000 | |
| Total Equity | 5,950,000,000 | 5,636,000,000 | 4,548,000,000 | 4,546,000,000 | 4,816,000,000 | |
| Free Cash Flow | 962,000,000 | 317,000,000 | -29,000,000 | 840,000,000 | 367,000,000 | |
| Cash from Operations | 1,220,000,000 | 605,000,000 | 263,000,000 | 1,126,000,000 | 673,000,000 | |
| Cash from Investing | -427,000,000 | -134,000,000 | -1,095,000,000 | -144,000,000 | -132,000,000 | |
| Cash from Financing | -353,000,000 | -974,000,000 | 1,141,000,000 | -827,000,000 | -684,000,000 | |
| Net Change in Cash | 371,000,000 | -469,000,000 | 286,000,000 | 55,000,000 | -180,000,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy